Transforming growth factor-alpha (TGF-α), a key ligand of the epidermal growth factor receptor (EGFR), plays a pivotal role in promoting drug resistance across multiple cancer types, including thyroid cancer. Here, EGFR is linked to thyroid gland carcinoma.